FASLG and systemic lupus erythematosus: aPL-(+) SLE patients showed a significant reduction in theexpression of four out of the six miRNAs in neutrophils in relation toaPL-(−) SLE patients (miR-124a, miR-125a, miR-222, and miR155) (Fig. 4B).